Stock Updates

Morning Trending Tickers: Edwards Lifesciences Corporation (NYSE: EW)

Edwards Lifesciences Corporation (NYSE: EW) is a large market cap stock with a market cap of 23.42 B. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 37.06, a forward P/E of 28.15 and EPS of 3.02. At a stock price of 111.95 (0.10%) it has a dividend yield of *TBA.

EPS growth for the last five years have been 21.40%, more recently this last year it has grown by 16.20%. The next year growth is going to be about 12.69% and more long-term 15.03% after five years. EPS growth quarter over quarter is 62.00%. Sales growth for the past five years have been 12.00% and sales growth quarter over quarter is 26.70%.

For performance, Edwards Lifesciences Corporation the past week has seen a gain of 1.54%. For the last month performance for Edwards Lifesciences Corporation is 15.78%. While the last quarter is 24.49% and half year, 25.91%. Finally for the year, performance is 12.19%.

The 52-week high for Edwards Lifesciences Corporation, is at -8.05%, and for the 52-week low it comes to a value of 38.01%. The 20-day simple moving average is 3.51% and 10.67% for the 200-day simple moving average.

Volatility for the week is at 2.13%, and for the month it is 1.80%. Edwards Lifesciences Corporation, has a target price of 118.42.

In terms of debt, long term debt/equity is 0.31, and for total debt/equity Edwards Lifesciences Corporation has 0.31. The gross margin is 73.60%, while operating margin is 26.90%, the profit margin is 20.80%. The current ratio is 3.5 and the quick ratio is 2.7.

Insider ownership is at 0.30%, with instituitional ownership at 90.30%. Edwards Lifesciences Corporation has a payout ratio of 0.00%. With the total shares outstanding coming to 209.16. The shares float is 207.96, with the float short at 0.98%, with short ratio coming to 1.03.

In terms of returns, the return on assets see Edwards Lifesciences Corporation, get 14.90%, with its returns on investment at 16.50%. Return on equity is 25.00%. So will the investors see the target price of 118.42, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

 Edwards Lifesciences Corporation (NYSE: EW)

About the author

Peter Clarke

Leave a Comment